CHIR 99021, 25 mg
To Order Now: info@anbioq.org
 CHIR 99021 trihydrochloride |
|||
| B1199-5 | Biovision | EUR 294 | |
) CHIR-99021 (monohydrochloride) |
|||
| HY-10182A | MedChemExpress | 50mg | EUR 725 |
) CHIR-99021 (trihydrochloride) |
|||
| HY-10182B | MedChemExpress | 50mg | EUR 725 |
) CHIR-99021 (CT99021) |
|||
| E1KS1263 | EnoGene | 2mg | EUR 325 |
CHIR-99021 (CT99021) |
|||
| A3011-10 | ApexBio | 10 mg | EUR 171 |
|
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?). |
|||
CHIR-99021 (CT99021) |
|||
| A3011-100 | ApexBio | 100 mg | EUR 693 |
|
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?). |
|||
CHIR-99021 (CT99021) |
|||
| A3011-5 | ApexBio | 5 mg | EUR 131 |
|
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?). |
|||
CHIR-99021 (CT99021) |
|||
| A3011-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 166 |
|
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?). |
|||
CHIR-99021 (CT99021) |
|||
| A3011-S | ApexBio | Evaluation Sample | EUR 81 |
|
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?). |
|||
CHIR 99021 trihydrochloride |
|||
| B5779-10 | ApexBio | 10 mg | EUR 224 |
CHIR 99021 trihydrochloride |
|||
| B5779-5 | ApexBio | 5 mg | EUR 145 |
 HCl) CHIR-99021 (CT99021) HCl |
|||
| A8396-10 | ApexBio | 10 mg | EUR 171 |
|
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?). |
|||
CHIR-99021 (CT99021) HCl |
|||
| A8396-100 | ApexBio | 100 mg | EUR 693 |
|
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?). |
|||
CHIR-99021 (CT99021) HCl |
|||
| A8396-5 | ApexBio | 5 mg | EUR 131 |
|
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?). |
|||
CHIR-99021 (CT99021) HCl |
|||
| A8396-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 142 |
|
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?). |
|||
CHIR-99021 (CT99021) HCl |
|||
| A8396-S | ApexBio | Evaluation Sample | EUR 81 |
|
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?). |
|||
 CHIR 99021, GSK-3 Inhibitor , HCl |
|||
| BC213-005 | GenDepot | 5 mg | EUR 286 |
CHIR 99021, GSK-3 Inhibitor , HCl |
|||
| BC213-025 | GenDepot | 25 mg | EUR 847 |
 CHIR 99021, GSK-3 Inhibitor , Free Base |
|||
| BC212-002 | GenDepot | 2 mg | EUR 178 |
CHIR 99021, GSK-3 Inhibitor , Free Base |
|||
| BC212-005 | GenDepot | 5 mg | EUR 265 |
CHIR 99021, GSK-3 Inhibitor , Free Base |
|||
| BC212-010 | GenDepot | 10 mg | EUR 315 |
CHIR 99021, GSK-3 Inhibitor , Free Base |
|||
| BC212-025 | GenDepot | 25 mg | EUR 394 |
CHIR 99021, GSK-3 Inhibitor , Free Base |
|||
| BC212-100 | GenDepot | 100 mg | EUR 887 |
 CHIR-090 |
|||
| B1852-25 | Biovision | EUR 675 | |
 CHIR-124 |
|||
| A8394-25 | ApexBio | 25 mg | EUR 340 |
|
Description: CHIR-124, a selective inhibitor, inhibits Chk1 with IC50 value of 0.3nM 2,000-fold more potently than Chk2 with IC50 value of 0.7?M. |
|||
 CHIR-98014 |
|||
| A8395-25 | ApexBio | 25 mg | EUR 374 |
|
Description: CHIR-98014 is a potent inhibitor of GSK-3? and GSK-3? with IC50 values of 0.65 nM and 0.58 nM, respectively [1]. |
|||
) Dovitinib (TKI-258, CHIR-258) |
|||
| A2168-25 | ApexBio | 25 mg | EUR 224 |
|
Description: Dovitinib (TKI258, CHIR-258) is a multitargeted receptor tyrosine kinase inhibitor against FLT3, KIT, FGFR, VEGFR, PDGFR? and PDGFR? with IC50 of 1 nM, 2 nM, 8-9 nM, 8-13 nM , 210 nM and 27nM, respectively [1]. |
|||
 Cyanine5.5 hydrazide, 25 mg |
|||
| 47070 | lumiprobe | 25 mg | EUR 316 |
 Cyanine5.5 maleimide, 25 mg |
|||
| 47080 | lumiprobe | 25 mg | EUR 316 |
 Cyanine5.5 amine, 25 mg |
|||
| 470C0 | lumiprobe | 25 mg | EUR 316 |
 Cyanine3 hydrazide, 25 mg |
|||
| 41070 | lumiprobe | 25 mg | EUR 316 |
 Cyanine3 maleimide, 25 mg |
|||
| 41080 | lumiprobe | 25 mg | EUR 316 |
 Cyanine3 amine, 25 mg |
|||
| 410C0 | lumiprobe | 25 mg | EUR 316 |
 Alkyne hydrazide, 25 mg |
|||
| 41770 | lumiprobe | 25 mg | EUR 101 |
 Alkyne maleimide, 25 mg |
|||
| 41780 | lumiprobe | 25 mg | EUR 101 |
 Cyanine5 hydrazide, 25 mg |
|||
| 43070 | lumiprobe | 25 mg | EUR 316 |
 Cyanine5 maleimide, 25 mg |
|||
| 43080 | lumiprobe | 25 mg | EUR 316 |
 Cyanine5 amine, 25 mg |
|||
| 430C0 | lumiprobe | 25 mg | EUR 316 |
 Cyanine7 hydrazide, 25 mg |
|||
| 45070 | lumiprobe | 25 mg | EUR 316 |
 Cyanine7 maleimide, 25 mg |
|||
| 45080 | lumiprobe | 25 mg | EUR 316 |
 Cyanine7 amine, 25 mg |
|||
| 450C0 | lumiprobe | 25 mg | EUR 316 |
 Cyanine7.5 tetrazine, 25 mg |
|||
| 460 | lumiprobe | 25 mg | EUR 513 |
 Cyanine7.5 hydrazide, 25 mg |
|||
| 46070 | lumiprobe | 25 mg | EUR 316 |
 Cyanine7.5 maleimide, 25 mg |
|||
| 46080 | lumiprobe | 25 mg | EUR 316 |
 Cyanine7.5 amine, 25 mg |
|||
| 460C0 | lumiprobe | 25 mg | EUR 316 |
 Pyrene hydrazide, 25 mg |
|||
| 43570 | lumiprobe | 25 mg | EUR 316 |
 Pyrene maleimide, 25 mg |
|||
| 43580 | lumiprobe | 25 mg | EUR 316 |
 Cyanine3.5 azide, 25 mg |
|||
| D2030 | lumiprobe | 25 mg | EUR 316 |
 Cyanine5 azide, 25 mg |
|||
| D3030 | lumiprobe | 25 mg | EUR 316 |